CD8A and infection: A study suggests that IL-7 plus 4-1BBL treatment; an immune checkpoint TNF receptor superfamily member 9 (4-1BB)/4-1BB ligand (4-1BBL) which improves the HCV-specific CD8+ T cell response; could improve HCV-specific cytotoxic T cell reactivity in patients with short/mid duration infections [134, 155].